Business Law.
Deals that survive antitrust review.
The work — Strategic acquisitions, minority investments, joint ventures, and the day-to-day commercial agreements that hold a business together. We treat antitrust as a litigation problem from the first model, not a filing exercise at the end.
What we cover — Cross-border M&A through second requests at the FTC, DOJ, and EU Commission. Public-company carve-outs and stand-alone IPO carve-outs. Bespoke joint ventures with competitors and parallel-track partnerships. Commercial agreements that survive disputes — supply, distribution, licensing, technology.
How we work — A named partner runs every deal from signing to close. The team that drafts the strategic narrative is the team that argues it in front of the regulator. Economic models, document discovery, and witness preparation are coordinated under one roof — no hand-offs to outside consultants who haven't read the deal documents.
Recent matter — A US-listed therapeutics company through a contested second request from the FTC and parallel EU Commission review. Clearance secured. Closed on schedule with no divestitures.
